Population‐based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study

OBJECTIVES: To evaluate the feasibility of a population‐based screening trial using prostate‐specific antigen (PSA), a kallikrein panel and multiparametric magnetic resonance imaging (MRI) aimed at minimizing overdiagnosis, while retaining mortality benefit. PATIENTS AND METHODS: Feasibility of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Rannikko, Antti, Leht, Mare, Mirtti, Tuomas, Kenttämies, Anu, Tolonen, Teemu, Rinta‐Kiikka, Irina, Kilpeläinen, Tuomas P., Natunen, Kari, Lilja, Hans, Lehtimäki, Terho, Raitanen, Jani, Kujala, Paula, Ronkainen, Johanna, Matikainen, Mika, Petas, Anssi, Taari, Kimmo, Tammela, Teuvo, Auvinen, Anssi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327584/
https://www.ncbi.nlm.nih.gov/pubmed/34958531
http://dx.doi.org/10.1111/bju.15683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327584/
https://www.ncbi.nlm.nih.gov/pubmed/34958531
http://dx.doi.org/10.1111/bju.15683

Ejemplares similares